Elanco signs research agreement with WEDterinary for $4M gene therapy in cats; four directors departing

Elanco Animal Health Inc

Board to shrink to 11 directors; Bilbrey, Turner, Wallace won't stand for re-election; Doyle resigned.
Research agreement with WEDterinary (33%-owned by Doyle) for targeted gene therapy treating chronic kidney disease in cats.
Elanco US will pay up to $4 million to fund WED research, securing negotiation rights to resulting IP.
Doyle will continue advising Elanco on animal health innovation; Paul Herendeen to chair Finance Committee.
Agreement funded within R&D operating expenses; approved by Audit Committee under related person policy.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William F. Doyle

Director

ELAN · Elanco Animal Health Inc

Effective: 2025-03-16
Filed: March 17, 2025, 7:59 PM ET

the Company announced certain changes to its Board of Directors, including the decision by William F. Doyle to resign from the Board, effective upon the Company entering into a research agreement

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William F. Doyle resigned as Director at Elanco Animal Health Inc.

Action: resigned
Role: Director

Exact text from the filing

the Company announced certain changes to its Board of Directors, including the decision by William F. Doyle to resign from the Board, effective upon the Company entering into a research agreement

View on SEC.gov

Elanco Animal Health Inc filing history →

Source: SEC EDGAR

accession 0001104659-25-024432

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.